Marie Pirotais: Driving Ultimate Progress 

Marie Pirotais | Co-founder and CEO | Biosency
Marie Pirotais | Co-founder and CEO | Biosency

With an intense earnestness for multidisciplinary collaboration where science, technology and business intersect, Marie Pirotais has been driving advancements in various sectors. She holds 25 years of experience in Research and Development (R&D) and innovation departments, where she has honed her expertise in strategy, marketing and project management.

In 2015, Marie co-founded Cataris, a consulting company focused on leveraging her diverse skill set to provide strategic insights and solutions to clients. Building on this foundation, she co-founded Biosency in 2017, a pioneering company dedicated to developing a predictive medicine solution based on specialized non-invasive physiological monitoring and digital health solutions.

Marie’s extensive background in R&D, coupled with her strategic acumen and marketing savvy, positions her as a visionary leader in the field of digital health. Her ability to bridge the gap between scientific advancements and market needs has been instrumental in guiding Biosency towards success in developing cutting-edge health monitoring technologies.

As the Co-founder and CEO of Biosency, Marie continues to drive innovation and spearhead initiatives that push the boundaries of what’s possible in digital health. Her dedication to integrating the latest technologies with a deep understanding of user needs underscores Biosency’s commitment to revolutionizing healthcare through non-invasive monitoring solutions.

Let us explore Marie’s transformative journey at Biosency, where innovation meets impact in the world of digital health.

Path to Healthcare Innovation

One of the most transformative experiences that profoundly shaped Marie’s leadership journey at Biosency was the recognition of the sheer potency in diverse perspectives. Co-founding Biosency alongside Yann Le Guillou, whose distinct background and thought processes diverged from her own, served as a stark revelation of the inherent strength found in diversity. This insight significantly influenced her approach to leadership within their team.

Understanding that diverse perspectives foster innovation and resilience, she actively sought to preserve and encourage this diversity within their organization. It wasn’t solely about individual skills but rather the collaborative intelligence that emerged when an array of unique viewpoints converged. This personal revelation proved instrumental in cultivating an inclusive and innovative culture at Biosency, propelling their collective efforts for personalized, predictive, and participative medicine to unprecedented heights.

Marie positioned Biosency as a leader in healthcare innovation and endeavored to meet their ambitious goals through several key strategies:

  • Substantial investment in talented R&D, medical, regulatory, and staff, as well as in clinical studies, to bring tangible medical proof to the market on their state-of-the-art predictive medicine solution. This highlighted their commitment to regulatory excellence, achieving CE MDR Class IIa certification as well as ANS certification (French Digital Health Agency) on cybersecurity and interoperability.
  • Prioritization of user experience through intuitive design and implementation of robust data security measures.
  • Collaboration with state-of-the-art research laboratories, manufacturers, healthcare professionals, and patients’ associations to build long-term partnerships.
  • Maintenance of the highest quality standards to meet the challenges of the healthcare sector.

They firmly believed that healthcare innovation, if not integrated into a care pathway, would not be able to deliver all its potential added value to the healthcare system.

AI-driven Solutions

Founded six and a half years ago, Biosency is a French start-up that provides predictive medicine solutions for patients suffering from chronic respiratory insufficiency. From the beginning, the company has focused on chronic obstructive pulmonary disease or COPD, an under-diagnosed pathology and the third leading cause of death globally. According to the WHO, over 400 million people worldwide suffer from the disease. COPD is characterized by inflammation and slow, generally progressive obstruction of the bronchial tubes.

In 80% of cases, it is linked to smoking, while the remaining 20% are caused by occupational diseases involving dust or pollution. Biosency’s cutting-edge technology harnesses the power of data analytics and real-time monitoring to detect respiratory issues early. Their AI-based predictive solutions improve patient care by enabling healthcare professionals to act upstream and anticipate deterioration in patient health to prevent hospitalization and patient re-admission.

By continuously tracking vital signs and scoring patient health status deterioration, Biosency empowers both patients and healthcare providers with actionable insights, fostering a proactive approach to respiratory care.

The company is dedicated to staying at the forefront of predictive medicine. Biosency aims to enhance the quality of life for patients and contribute to a more sustainable healthcare ecosystem.

Rising to the Challenge

During the height of the first COVID-19 pandemic lockdown in March 2020, Marie recounts the challenging situation Biosency faced when their subcontractor, responsible for manufacturing their cutting-edge Bora band vital sign wristbands, suddenly halted production.

This unexpected disruption left them with a severely limited supply, unable to meet the overwhelming demand from hospitals and pulmonologists for their recently CE DM Class IIa certified remote monitoring solution. This certification was crucial in facilitating the safe return home of patients requiring oxygen therapy.

Determined to overcome this obstacle, Marie and her team tapped into their extensive local economic network. Through their efforts, they successfully obtained prefectural authorization to reopen the factory during the lockdown period.

This bold and proactive move allowed Biosency to swiftly resume production of their Bora band wristbands, meeting the critical needs of hospitals and pulmonologists who relied on their solution for ensuring the secure at-home recovery of patients on oxygen therapy.

Advancing Respiratory Care

Biosency adopts a strategic approach to collaborations and partnerships, aiming to amplify its impact and extend its reach within the healthcare industry. Marie and her team prioritize the establishment of alliances with key stakeholders, including industry leaders, research institutions, and healthcare organizations.

By actively engaging patient associations as partners, Biosency ensures that its solutions are not only technologically advanced but also deeply attuned to the needs and experiences of those affected by respiratory conditions. This inclusive approach underscores the company’s commitment to developing patient-centric solutions that address real-world challenges and enhance the overall quality of care.

These collaborations serve as catalysts for innovation, enabling Biosency to leverage collective expertise, share knowledge, and remain at the forefront of advancements in medical technology.

Commitment to Innovation and Patient-Centricity

Marie emphasizes that at Biosency, the team prioritizes continuous innovation, agility, and patient-centricity, ensuring that their solutions drive tangible improvements in healthcare outcomes. Through strategic collaboration and partnerships, they amplify their impact within the industry, guided by data-driven decision-making, regulatory excellence, and determined ethical standards. With a global vision guiding their international expansion and a steadfast dedication to nurturing talent, they empower a dynamic poised for success.

Customer feedback holds utmost importance, serving as the driving force behind their adaptability to the ever-changing landscape of healthcare. Rooted in core values of ethics, commitment, professionalism, and trust, these principles foster a culture of unparalleled excellence, resilience, and unwavering responsiveness. At Biosency, it’s their dedicated team that embodies and champions these fundamental values, propelling them towards continued success.

Listening intently, demonstrating empathy, and valuing the expertise of each individual are the cornerstones of their commitment to shaping the future of respiratory care.

Revolutionizing Healthcare with Predictive Medicine

With an aging population, a surge in chronic illnesses, the aging of healthcare professionals, and the prevalence of medical deserts, Marie emphasizes the urgent need for transformation in our healthcare system. Biosency aims to play a pivotal role in this transformation by providing the technological foundation to advance predictive medicine and telemonitoring. The integration of telemonitoring not only empowers patients with confidence but also ensures seamless continuity of care at home on a global scale.

Also, establishing a solid legal framework is paramount to ensure patient safety, device efficacy, and interoperability. Biosency is fully committed to aligning with this framework, paving the way for reimbursement from the French health insurance system. Additionally, the company is diligently preparing for FDA clearance, with approval anticipated by 2025.

The Roadmap to Success in Healthcare Leadership

Marie advises aspiring healthcare leaders that navigating challenges and fostering innovation are paramount for success. First and foremost, she suggests embracing challenges as opportunities for growth and learning. The healthcare landscape is dynamic, and adversity often serves as a catalyst for innovation.

Therefore, it’s crucial to cultivate an environment that encourages open communication and seamless collaboration within your team and with external partners. Marie emphasizes that it’s the fusion of diverse perspectives that fuels and fortifies strength. She recommends prioritizing patient-centric approaches, developing unyielding resilience, and leading with a blend of empathy and humility.

By embracing these principles, healthcare leaders can not only navigate challenges effectively but also drive a culture of continuous innovation in healthcare.

Read More: Click Here